Cost, quality, and risk: measuring and stopping the hidden costs of coronary artery b

This is a discussion on Cost, quality, and risk: measuring and stopping the hidden costs of coronary artery b within the Medical Articles and Abstracts forum; Morgan TO. Am J Health Syst Pharm. 2005 Sep 15;62(18 Suppl 4):S2-5. Pennsylvania Hospital, 800 ...


Notices

 
LinkBack Thread Tools Search this Thread Rate Thread Display Modes

Reply
  #1 (permalink)  
Old 09-27-2006, 06:42 AM
LarryEitel's Avatar
Executive Director
 
Join Date: Apr 1996
Posts: 636
Thanks: 50
Thanked 69 Times in 28 Posts
LarryEitel is on a distinguished road
Cost, quality, and risk: measuring and stopping the hidden costs of coronary artery b

Morgan TO. Am J Health Syst Pharm. 2005 Sep 15;62(18 Suppl 4):S2-5. Pennsylvania Hospital, 800 Spruce Street, Philadelphia, PA 19107, USA. timorg@pahosp.com

PURPOSE: Blood conservation programs have been successfully implemented in hospitals in which an overarching commitment to the reduction of the number of blood transfusions existed. This review will describe the rationale and some of the considerations involved in starting such a program.

SUMMARY: Management of a hospital's blood supply is a high pressure area dominated by a resource shortage, increasing costs, a medical community that has been trained to use transfusion, public awareness and concern, and to a lesser extent an increasing body of evidence suggesting that transfusions are often deleterious. The implementation of new techniques and protocols to conserve blood during surgery can be facilitated if a physician champion addresses the medical staff and the hospital administrators clear political and budgetary issues. With a team approach and an understanding of the clinical and economic evidence supporting less blood use, many of the hurdles can be overcome.

CONCLUSION: Blood conservation programs offer a solution to the multiple problems that surround blood use. When successfully implemented, such initiatives reduce safety concerns, hospital spending, and the dependency of hospitals on the national blood supply and improve clinical outcomes and patient satisfaction.

Full text of this item requires a subscription to American Journal of Health-System Pharmacy Online

__________________
Larry Eitel
Webmaster

Click here and see who are advancing transfusion alternatives and blood management.

Can you spare a cup of coffee? Click here.
Thank you.
Digg this Post!Add Post to del.icio.usBookmark Post in TechnoratiFurl this Post!
Reply With Quote
Reply
Tags
cost, costs, coronary, artery



Currently Active Users Viewing This Thread: 1 (0 members and 1 guests)
 
Thread Tools Search this Thread
Search this Thread:

Advanced Search
Display Modes Rate This Thread
Rate This Thread:

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On
Trackbacks are On
Pingbacks are On
Refbacks are On

Similar Threads
Thread Thread Starter Forum Replies Last Post
Mortality associated with aprotinin during 5 years following coronary artery bypass g dhcatlady Medical Articles and Abstracts 0 06-10-2007 10:58 PM
Mortality associated with aprotinin during 5 years following coronary artery bypass.. Sharon Grant Medical Articles and Abstracts 0 03-02-2007 07:10 PM
Study of five cell salvage machines in coronary artery surgery Jan B. Wade Medical Articles and Abstracts 0 02-06-2004 09:55 AM
Coronary Artery Bypass Editors Glossary of Terms 0 11-29-2003 02:56 PM
Blood Use in Patients Undergoing Coronary Artery Bypass Surgery jmarti49 Medical Articles and Abstracts 0 09-24-2003 10:27 AM